Nestle Health Science SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nestle Health Science SA - overview
Established
2011
Location
Vevey, -, Switzerland
Primary Industry
Food
About
Nestle Health Science SA, based in Switzerland, focuses on developing innovative nutritional products that cater to diverse health needs, enhancing wellness from pediatrics to healthy aging. Nestle Health Science SA is dedicated to providing nutritional solutions aimed at specific health requirements. Founded in 2011 in Vevey, Switzerland, the company has seen shifts in business strategy to better align with the evolving health and wellness market. The executive team includes CEOs Abigail Buckwalter, Caroline Charlesworth, Cecily Gu, and Don Kerrigan.
Nestlé Health Science specializes in developing and providing innovative nutritional products designed to address various health needs across all life stages, from pediatrics to healthy aging. The company's primary offerings include medical nutrition solutions tailored for individuals with specific health conditions, such as malnutrition and cow's milk protein allergies, and active lifestyle nutrition products aimed at enhancing overall wellness. Key product lines include PEPTAMEN® for critical care patients, VITAFLO® for metabolic disorders, and BOOST® nutritional shakes designed for seniors. Their extensive portfolio serves healthcare providers, patients, and consumers across multiple geographic markets, including North America, Europe, and parts of Asia, thereby contributing to improved health outcomes in diverse populations.
Nestlé Health Science generates revenue through a structured approach that includes direct sales to healthcare facilities, partnerships with retailers, and B2B transactions, primarily targeting healthcare professionals and institutions. The company’s flagship products, such as PEPTAMEN® and BOOST®, are sold through various channels including pharmacies, hospitals, and specialized nutrition retailers. Transactions typically involve bulk purchasing agreements with healthcare providers, while some products may also be available for direct consumer purchase via retail outlets. The pricing strategies employed by Nestlé Health Science reflect the premium nature of their specialized nutritional products, positioning them as essential solutions for health management rather than standard consumer goods.
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Pharmaceuticals
Website
www.nestlehealthscience.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Nestle Health Science SA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | GO Healthy New Zealand Ltd | - | ||||||||
| Trade Sale | Completed | PronoKal Health Group SL | - | ||||||||
| Trade Sale | Completed | Orgain, Inc. | - | ||||||||
| Trade Sale | Completed | Nuun & Company Inc. | - | ||||||||
| Trade Sale | Completed | Atrium Innovations, Inc. | - |
Displaying 1 - 5 of 7
Nestle Health Science SA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.